Half Year 2025 Verici DX PLC Earnings Call Transcript
Good morning, and welcome to the Verici Dx plc interim results investor presentation. (Operator Instructions)
Before we begin, we would like to submit the following poll. I'd now like to hand you over to CEO, Sara Barrington. Good morning.
Good morning, everybody. And I will just move to the slides. Thank you. Just want to welcome everybody to the interim roadshow for the first half of 2025 and also a follow-up meeting after our financing event, which closed two months ago. So just as a quick reminder about who Verici is, we are a kidney transplant company with three products, two of which are commercialized. And we are at a pivotal point. The last financing was enabling us to move from a milestone-based company into a commercial growth company. We are moving forward on that.
So the company has raised GBP37.5 million to date to walk through the -- all the milestones to get to commerciality. And we have two products. I will go through the products in due course. But
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
